• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Invitae | Genelex

Invitae | Genelex

Pharmacogenetics Makes Precision Medicine Possible

  • For Patients
    • Conditions
    • Affected Drugs
    • What is PGx?
    • Resources
    • FAQs
  • For Providers
    • Conditions
    • Resources
    • Order Testing Supplies
  • Test Menu
  • Clinical Trials
  • About
    • Lab Accreditations
    • Genelex Team
    • Contact Us
  • Log In

People of Note: Dr. Eric Topol

Home / News / People of Note: Dr. Eric Topol

Genelex Blog

People of Note: Dr. Eric Topol

If personalized medicine had to choose a figurehead, Dr. Eric Topol would be a pretty good choice. Voted the #1 Most Influential Physician Executive in 2012, Dr. Topol is the director and founder of the Scripps Translational Science Institute and has been involved in the development of many major drugs, devices and genomic practices. He’s been involved in the publication of more than a thousand scientific papers and reports and holds many honors.

Genelex knows that although pharmacogenetics is an important part of personalized medicine, the field isn’t just prescribing the best drugs – it’s redefining how physicians obtain, coordinate, understand and use patient data across the entire lifetime of the patient. The Scripps Institute seeks to foster interdisciplinary research, train and teach young faculty and partners, and build the infrastructure necessary for personalized medicine.

Follow Dr. Topol on Twitter at @EricTopol, read his take on genomic medicine, or watch his TED talk on wearable medical devices.

Genelex Resources

Affected Conditions
Affected Drugs
Info for Providers
Frequently Asked Questions
Contact Genelex
Join Our Mailing List

Footer

CONTACT US

(800) 837-8362
info@genelex.com

3101 Western Ave.
Suite 100
Seattle, WA 98121

HELPFUL INFORMATION

What is PGx?
Test Menu
Conditions
Affected Drugs
FAQs
References

ABOUT GENELEX

Blog
News
Genelex Team
Lab Accreditations
Contact Us
Privacy Practices
Privacy Policy

  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • YouTube

KEEP IN TOUCH

Stay in the loop with news and updates from Genelex and be among the first to know when new tests become available.